Authors: | Lee, C. H.; Li, C.; Perini, R. F.; Hoehn, D.; Albiges, L. |
Abstract Title: | KEYNOTE-B61: Open-label phase 2 study of pembrolizumab in combination with lenvatinib as first-line treatment for non-clear cell renal cell carcinoma (nccRCC) |
Meeting Title: | 2021 ASCO Annual Meeting |
Journal Title: | Journal of Clinical Oncology |
Volume: | 39 |
Issue: | 15 Suppl. |
Meeting Dates: | 2021 Jun 4-8 |
Meeting Location: | Virtual |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2021-05-20 |
Language: | English |
ACCESSION: | WOS:000708120306288 |
DOI: | 10.1200/JCO.2021.39.15_suppl.TPS4595 |
PROVIDER: | wos |
Notes: | Meeting Abstract: TPS4595 -- Source: Wos |